NeuroSearch A/S will bank as much as €32 million (US$45.1 million) in guaranteed funding over the next three years on the strength of a new drug discovery and development alliance in central nervous system disease with Janssen Pharmaceutica NV, a subsidiary of Johnson & Johnson Co., of New Brunswick, N.J. (BioWorld International)